The Novavax COVID-19 vaccine, also referred to as Nuvaxovid, was discontinued in Australia in May 2025. Novavax stopped producing the original Novavax vaccine formulation in early 2022, and the last batch expired on January 31, 2024.
Previously, the Australian Technical Advisory Group on Immunisation (ATAGI) recommended Novavax as a booster option for individuals aged 18 and over when mRNA vaccines were not suitable . However, due to limited data on its safety and immunogenicity as a booster, it was not TGA-registered for this specific use .AusVaxSafety+3Health.gov.au+3NSW Health & Medical Research+3Health.gov.au+2nitag-resource.org+2Mvec+2
As of now, there is no updated Novavax booster approved or available in Australia. The updated Novavax booster has not yet been submitted for approval to the Therapeutic Goods Administration (TGA), so its availability in Australia may still be some time away .InSight+
For those seeking booster vaccinations, mRNA vaccines such as Pfizer and Moderna remain the primary options available in Australia. These vaccines have been widely administered and are supported by extensive safety and efficacy data.Health.gov.au+4AHA+4Cancer Australia+4
If you have concerns or specific health considerations regarding COVID-19 vaccination, it’s advisable to consult with a healthcare professional to determine the most appropriate vaccine option for your circumstances.